Moore Capital Management’s Select Medical SEM Stock Holding History

Moore Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-145,500	Closed	-$2.37M	–	819
2026 Q1	$2.37M	Buy	145,500 +120,500	+482%	+$1.89M	0.05%	261
2025 Q4	$371K	Buy	+25,000	New	+$353K	0.01%	510
2016 Q1	–	Sell	-892,736	Closed	-$5.73M	–	331
2015 Q4	$5.73M	Buy	+892,736	New	+$5.58M	0.18%	137

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Moore Capital Management's SEM Position: Q2 2026 in Review

Moore Capital Management sold out of Select Medical (SEM) in Q2 2026, closing a stake of 145,500 shares — an estimated $2.37M sold.

Moore Capital Management first reported a position in SEM in Q4 2015 and held it in 3 quarters. The position peaked at $5.73M in Q4 2015. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Moore Capital Management reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
Moore Capital Management sold 145,500 Select Medical shares in Q2 2026, an estimated $2.37M.
Moore Capital Management first reported a position in Select Medical in Q4 2015 and held it in 3 quarters.
Moore Capital Management's Select Medical position peaked at $5.73M in Q4 2015.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.